1988
DOI: 10.1097/00007632-198802000-00001
|View full text |Cite
|
Sign up to set email alerts
|

Twenty-four-hour Growth Hormone Profiles in Pubertal Girls with Idiopathic Scoliosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
19
0

Year Published

1993
1993
2022
2022

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 35 publications
(20 citation statements)
references
References 0 publications
1
19
0
Order By: Relevance
“…Melatonin appears to act through an essentially indirect mechanism. Altered growth hormone secretion has been suggested to be one of pathogenic factors underlying idiopathic scoliosis [3]. Secretions of melatonin and growth hormone reportedly show reciprocal diurnal fluctuations in rats [35].…”
Section: Discussionmentioning
confidence: 99%
“…Melatonin appears to act through an essentially indirect mechanism. Altered growth hormone secretion has been suggested to be one of pathogenic factors underlying idiopathic scoliosis [3]. Secretions of melatonin and growth hormone reportedly show reciprocal diurnal fluctuations in rats [35].…”
Section: Discussionmentioning
confidence: 99%
“…The rapid growth associated with GH may aggravate this spinal deformity. Some authors have described an association between increased GH levels and a higher rate of curve progression in children without PWS33-35). In contrast to these reports, a randomized controlled trial in a large group of children with PWS showed no significant difference between GH-treated children and randomized controls with regard to the onset of scoliosis, curve progression, and start of treatment of scoliosis36).…”
Section: Gh Deficiency In Pwsmentioning
confidence: 95%
“…(2) increased levels of circulating growth hormone (GH)[136,307,308] for age in AIS girls notably from 7-12 years, and in pubertal stage 2, and/or IGF-I formerly known as somatomedin C [5,309]. …”
Section: Endocrine and Therapeutic Implicationsmentioning
confidence: 99%
“…(8) Evaluation of circulating hormones - leptin [12,163,164,206,207,381], high affinity leptin binding protein (soluble leptin receptor) [378,379], growth hormone [307,308], IGF-I and binding proteins [5,379], and estrogen levels [307,327-329] - in AIS girls by relatively higher and lower BMI subsets, with a view ultimately to a possible clinical trial of medical treatment by a somatostatin analogue [319] and β-blockers [199]. Cross-sectional [163,164] and longitudinal [12,381] studies are needed.…”
Section: Testing the Theorymentioning
confidence: 99%